Allergic bronchopulmonary aspergillosis
Authors:
L. Heribanová
Authors place of work:
Přednosta: prof. MUDr. Jiří Homolka, DrSc.
; Primářka: doc. MUDr. Martina Vašáková, PhD.
; Pneumologická klinika 1. LF UK a Thomayerovy nemocnice, Praha
Published in the journal:
Prakt. Lék. 2014; 94(2): 59-63
Category:
Reviews
Summary
Allergic bronchopulmonary aspergillosis (ABPA) is a Th2 hypersensitive response to A. fumigatus colonization of airways in predisposed persons, that predominantly affects asthmatic and cystic fibrosis patients. A number of genetic risk factors have been identified to play a role in the development of ABPA. The diagnostic assessment ABPA is based on the presence of a combination of clinical, laboratory and radiological findings, the early detection of the disease and the adequate treatment have a major effect on the prognosis of patients.
Keywords:
allergic bronchopulmonary aspergillosis – asthma bronchiale – A. fumigatus
Zdroje
1. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135(3): 805–825.
2. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33(2): 177–186.
3. Eaton T, Garrett J, Milne D, et al. Allergic bronchopulmonary aspergillosis in the astma clinic: A prospective evaluation of CT in diagnostic algorithm. Chest 2000; 113(1): 66–72.
4. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62(3): 276–277.
5. Fila L. Alergická bronchopulmonální aspergiloza. In Vávrová, V. a kol. Cystická fibróza. Praha: Grada Publishing 2006; 212–216.
6. Greenberger PA. Clinical aspects of allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8: 119–127.
7. Gupta, RK, Chandra A, Gautam PB. Allergic bronchopulmonary aspergillosis – a clinical rewiew. J Assoc Physicians India 2012; 60: 46–51.
8. Haber J. Hodnocení galaktomananu v séru a bronchoalveolární laváži u neutropenických a non-neutropenických pacientů. Kazuistiky v alergologii, pneumologii a ORL 2011, č. 2: 10–13.
9. Hemmann S, Menz G, Ismail C, et al. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A. fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999; 104(3Pt1): 601–607.
10. Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndrome. Semin Respir Crit Care Med 2011; 32(6): 682–692.
11. Judson MA. Allergic bronchopulmonary aspergillosis. PCCU 2005; 17: 1–11.
12. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in astma and cystic fibrosis. Clin Dev Immunol, 2011, ID 843763 [on-line]. Dostupné na: downloads.hindawi.com/journals/cdi/2011/ 843763.pdf.
13. Kumar R. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Chest 2003; 124(3): 890–892.
14. Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol 2000; 18: 181–185.
15. Malíř F, Ostrý V. Přehled a charakteristika významných vláknitých mikromycetů. In Malíř, F., Ostrý, V. a kol. Vláknité mikromycety (plísně), mykotoxiny a zdraví člověka. Brno: Národní centrum ošetřovatelství a nelékařských zdravotnických oborů 2003: 105–142.
16. Marchant E, Verrelen-Dumoulin C, Mairesse M, et al. Frequency of cystic fibrosis transmembrane conductance regulatore gene mutations and 5T allele in pacients with allergic bronchopulmonary aspergillosis. Chest 2001; 119: 762–767.
17. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000; 16(3): 464–467.
18. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982; 96: 286–291.
19. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Am Thorac Soc 2010; 7(3): 237–244.
20. Radojicic C. Allergic bronchopulmonary aspergillosis [on-line]. London: BMJ Publishing Group Ltd. 2011. Dostupné na: http://bestpractice.bmj.com/best-practice/monograph/836.
21. Richerson HB. Choroby plic z přecitlivělosti. In Berkow R, Fletcher AJ. Merck Manual (české vydání). Praha: X-Egem 1996; 632–633.
22. Ringer S, Hilpler UCh, Elsner P, et al. Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Pediatr Pulmonol 2007; 42: 314–318.
23. Sarkar A, Mukherjee A, Ghoshal AG, et al. Occurrence of allergic bronchopulmonary mycosis in patients with asthma: An Eastern India experience. Lung India 2010; 27(4): 212–216.
24. Sharma B, Sharma M, Bondi E, Sharma M. Kartagener’s syndrome associated with allergic bronchopulmonary aspergillosis. MedGenMed 2005; 7(2): 25.
25. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007; 101(6): 1163–1170.
26. Skov M, Pressler T, Jensen HE, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54(1): 44–50.
27. Skřičková J. Difusní parenchymové nemoci plic známé etiologie. In Marek J. a kol. Farmakoterapie vnitřních nemocí. 4., zcela přepracované a doplněné vydání. Praha: Grada Publishing 2010; 176–180.
28. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37(Suppl): 225–264.
29. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009; 10(1): 37–42.
30. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005; 60: 1004–1013.
31. Vašáková M. Vzácné intersticiální plicní procesy. In Kolek V. a kol. Pneumologie. Praha: Maxdorf 2011; 283.
32. Wark PA, Salton N, Simpson J, et al. Induced sputum eosinophils and neutrophils and bronchiectasis in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16: 1095–1101.
33. Zander DS. Update on allergic bronchopulmonary aspergilosis. Abstracts of 99th Annual Meeting USCAP, 2010, Washington [on-line]. Dostupné na: http://www.uscap.org/site~/99th/pdf/companion05h04.pdf.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2014 Číslo 2
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole vs. Tramadol in Postoperative Analgesia
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
Najčítanejšie v tomto čísle
- Assessment of fitness to work at night
- Laxatives – safe and effective
- Allergic bronchopulmonary aspergillosis
- Up-to-date radiotherapy for prostate cancer